Viewing Study NCT01804218


Ignite Creation Date: 2025-12-25 @ 4:46 AM
Ignite Modification Date: 2026-02-28 @ 8:49 PM
Study NCT ID: NCT01804218
Status: UNKNOWN
Last Update Posted: 2016-08-09
First Post: 2013-03-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
Sponsor: Invion, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module